Advertising Regulatory Board scrutinises smart technology health assessment claims
Image: File Picture
A radio advertisement regarding new smart technology which is said to be capable of doing a health assessment by measuring blood pressure came under the spotlight by the Advertising Regulatory Board (ARB) following a complaint by a member of the public.
The commercial features Afrikaans dialogue between 'Johan' and 'clever Werner' of Momentum. Werner proceeds to promote the advertiser's new smart technology with a "selfie video". Werner notes that this technology measures heart rate, blood pressure, oxygen, and stress levels on your smartphone.
The complainant submitted that smartphone applications, such as the one promoted, do not 'measure' blood pressure. They can only calculate it by using data provided. It is dangerous to claim that this application can 'measure' high pressure, as mistakes could lead to death, the complaint read.
The advertiser explained that its application relies on smartphone-enabled remote photoplethysmography, a technology that estimates vital signs— including blood pressure— based on subtle changes in skin colouration detected via the camera. This technology is not speculative or experimental; it has been widely used in clinical environments for years, it said.
The advertiser explained that it has partnered with an international provider who operates on the cutting edge of this technology. It said the advertised service allows customers to gain insights into their vital signs, and it (the advertiser) has taken care not to promote this as a substitute for a medical device or clinical diagnosis.
The directorate, in giving the green light to the advertisement, stressed that its decision should not be interpreted as expressing a view on the advertiser's technology. It can only determine whether the communication used to advertise such technology is possibly misleading, dishonest, or irresponsible in a way that the Code of Advertising Practice seeks to prevent.
It pointed out that the dispute is about the wording used in this commercial and not the technology on which the advertiser relies.
The complainant objected to the term 'measure' used and said that the smartphone app does no measuring and merely calculates or tracks blood pressure based on certain data.
The directorate agreed that this would not constitute a 'measurement' as much as it would constitute a report or the tracking of one's blood pressure.
However, from the advertiser's submissions, it would appear that its app does not simply track or report one's blood pressure but actually uses remote photoplethysmography to calculate and return a blood pressure reading.
While true that this is not the same means of measurement that people have become accustomed to, such as inflating and deflating a cuff around the arm, it could reasonably be said that this constitutes a 'measurement,' as live readings and measurements are taken in real-time, the ARB stated.
It added that, contrary to the complainant's submissions, this does not appear to simply be the reporting or prediction of blood pressure readings but an actual measurement using different technology to measure blood flow.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
IOL News
2 days ago
- IOL News
Advertising Regulatory Board scrutinises smart technology health assessment claims
The Advertising Regulatory Board had to decide whether a commercial, which advertised smart technology in relation to assessing blood pressure, was irresponsible or not. Image: File Picture A radio advertisement regarding new smart technology which is said to be capable of doing a health assessment by measuring blood pressure came under the spotlight by the Advertising Regulatory Board (ARB) following a complaint by a member of the public. The commercial features Afrikaans dialogue between 'Johan' and 'clever Werner' of Momentum. Werner proceeds to promote the advertiser's new smart technology with a "selfie video". Werner notes that this technology measures heart rate, blood pressure, oxygen, and stress levels on your smartphone. The complainant submitted that smartphone applications, such as the one promoted, do not 'measure' blood pressure. They can only calculate it by using data provided. It is dangerous to claim that this application can 'measure' high pressure, as mistakes could lead to death, the complaint read. The advertiser explained that its application relies on smartphone-enabled remote photoplethysmography, a technology that estimates vital signs— including blood pressure— based on subtle changes in skin colouration detected via the camera. This technology is not speculative or experimental; it has been widely used in clinical environments for years, it said. The advertiser explained that it has partnered with an international provider who operates on the cutting edge of this technology. It said the advertised service allows customers to gain insights into their vital signs, and it (the advertiser) has taken care not to promote this as a substitute for a medical device or clinical diagnosis. The directorate, in giving the green light to the advertisement, stressed that its decision should not be interpreted as expressing a view on the advertiser's technology. It can only determine whether the communication used to advertise such technology is possibly misleading, dishonest, or irresponsible in a way that the Code of Advertising Practice seeks to prevent. It pointed out that the dispute is about the wording used in this commercial and not the technology on which the advertiser relies. The complainant objected to the term 'measure' used and said that the smartphone app does no measuring and merely calculates or tracks blood pressure based on certain data. The directorate agreed that this would not constitute a 'measurement' as much as it would constitute a report or the tracking of one's blood pressure. However, from the advertiser's submissions, it would appear that its app does not simply track or report one's blood pressure but actually uses remote photoplethysmography to calculate and return a blood pressure reading. While true that this is not the same means of measurement that people have become accustomed to, such as inflating and deflating a cuff around the arm, it could reasonably be said that this constitutes a 'measurement,' as live readings and measurements are taken in real-time, the ARB stated. It added that, contrary to the complainant's submissions, this does not appear to simply be the reporting or prediction of blood pressure readings but an actual measurement using different technology to measure blood flow.
IOL News
6 days ago
- IOL News
Controversial Med-Lemon ad: ARB's ruling on graphic sneeze sparks debate
The Advertising Regulatory Board took a closer look at a Med-Lemon advertisement following complaints, but gave it the green light. Image: File A med-Lemon advertisement depicting a graphic sneeze with mucus flying over others has sparked two complaints to the Advertising Regulatory Board (ARB). However, the ARB concluded that while the ad teeters on the edge of being 'gross' and 'offensive,' it does not breach advertising standards. One complaint described the ad as 'very disgusting and disturbing to watch,' arguing that it fails to promote hygiene, especially in the wake of the Covid-19 pandemic, and is in poor taste. The second complaint was in a similar vein, with a member of the public who saw the TV advertisement being disgusted by the sneezing person's bodily fluids spraying all over people. The advertiser responded that they recognise the heightened sensitivity around respiratory illnesses, especially in the wake of the Covid-19 pandemic, but they assured that this was carefully considered in their approach. The advertiser stated that their primary objective with the campaign was to address a critical public health challenge: the significant impact of influenza in South Africa. While Covid-19 has been a focus, the advertiser stated that it is important to remember that influenza remains a serious threat. 'Flu paints a bleak picture,' it said. According to the advertiser, the exaggerated dramatisation of a sneeze and the personal and social chaos it creates was a deliberate creative choice. 'By vividly portraying the unpleasant consequences of delayed treatment via exaggerated dramatisation, we aim to make consumers realise the importance of acting at the very first sign of symptoms,' the advertising company explained. It said this approach, while bold, is reasonable and justifiable in an open and democratic society, as it directly promotes public health and is proportionate to the significant societal concern surrounding respiratory illnesses. In analysing the advertisement, the directorate of the ARB said it has no difficulty in concurring that the sneeze depicted in the advertisement is unpleasant to watch. 'Bodily fluids are a significant disgust trigger for the average consumer, and this commercial certainly hits the mark for many consumers. That being said, disgust felt on the part of a viewer does not necessarily mean that an advertisement is in and of itself offensive,' it said. The directorate noted that the purpose of this commercial, as outlined by the advertiser, is to prevent an outcome such as the unpleasant sneeze. It said it understands that the audience is supposed to be disgusted by the sneezing man. The commercial delivers the message, loud and clear, that going out in public with raging respiratory infection symptoms affects all those around us, it said. Get your news on the go, click here to join the Cape Argus News WhatsApp channel. Cape Argus
IOL News
6 days ago
- IOL News
Pelargonium: A traditional remedy from the Eastern Cape that fights viruses
In South Africa, we're surrounded by a rich heritage of traditional healing. But it's not every day that one of our indigenous plants steps out of that tradition and into the global spotlight, backed by modern science. That's exactly what's happening with Pelargonium sidoides, an indigenous plant from the Eastern Cape, Free State, and Lesotho. Pelargonium has several common names including kalwerbossie, rabassamin, rooi rabas (Afrikaans), and umckaloabo (isiZulu). In English, it is also known as black pelargonium This plant is a testament to the power of our local knowledge and a perfect example of how ancient remedies can be validated by contemporary research to offer real benefits in modern healthcare. Long before it was bottled and sold in pharmacies, Pelargonium sidoides was a trusted remedy among indigenous healers. Its journey to mainstream medicine began in a fascinating way in 1897, when a man named Major Charles Stevens, suffering from tuberculosis, found himself on the path to recovery after being treated with medicine made from the plant's root by a Zulu healer.
